Phase II Randomized Study of Neoadjuvant Metformin Plus Letrozole vs Placebo Plus Letrozole for ER-positive Postmenopausal Breast Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Letrozole (Primary) ; Metformin
- Indications Breast cancer
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms METEOR
- 10 Sep 2018 Biomarkers information updated
- 20 Mar 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea, KCT0000674).
- 08 May 2012 New trial record